Daiichi Sankyo Company, Limited Just Recorded A 8.3% EPS Beat: Here's What Analysts Are Forecasting Next
Daiichi Sankyo Company, Limited (TSE:4568) just released its latest third-quarter results and things are looking bullish. The company beat expectations with revenues of JP¥485b arriving 2.2% ahead of forecasts. Statutory earnings per share (EPS) were JP¥32.82, 8.3% ahead of estimates. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.
View our latest analysis for Daiichi Sankyo Company
After the latest results, the 17 analysts covering Daiichi Sankyo Company are now predicting revenues of JP¥2.09t in 2026. If met, this would reflect a solid 16% improvement in revenue compared to the last 12 months. Per-share earnings are expected to rise 9.3% to JP¥143. In the lead-up to this report, the analysts had been modelling revenues of JP¥2.09t and earnings per share (EPS) of JP¥143 in 2026. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.
There were no changes to revenue or earnings estimates or the price target of JP¥6,217, suggesting that the company has met expectations in its recent result. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. The most optimistic Daiichi Sankyo Company analyst has a price target of JP¥7,600 per share, while the most pessimistic values it at JP¥5,500. These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.
Of course, another way to look at these forecasts is to place them into context against the industry itself. We can infer from the latest estimates that forecasts expect a continuation of Daiichi Sankyo Company'shistorical trends, as the 13% annualised revenue growth to the end of 2026 is roughly in line with the 14% annual growth over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenues grow 4.4% per year. So it's pretty clear that Daiichi Sankyo Company is forecast to grow substantially faster than its industry.
The Bottom Line
The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.
With that in mind, we wouldn't be too quick to come to a conclusion on Daiichi Sankyo Company. Long-term earnings power is much more important than next year's profits. We have forecasts for Daiichi Sankyo Company going out to 2027, and you can see them free on our platform here.
Plus, you should also learn about the 1 warning sign we've spotted with Daiichi Sankyo Company .
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSE:4568
Daiichi Sankyo Company
Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.
Undervalued with excellent balance sheet.